P. Richardson

发表

H. Barnes, P. Richardson, 1973, The Journal of obstetrics and gynaecology of the British Commonwealth.

Using a rhabdomyosarcoma patient‐derived xenograft to examine precision medicine approaches and model acquired resistance

J. Junewick, N. Monks, E. Eugster, 2014, Pediatric blood & cancer.

Genomic characterization of explant tumorgraft models derived from fresh patient tumor tissue

Yuri Nikolsky, Robin E Everts, Patrick J Richardson, 2012, Journal of Translational Medicine.

MicroRNA 92a-2*: A Biomarker Predictive for Chemoresistance and Prognostic for Survival in Patients with Small Cell Lung Cancer

Aarati R. Ranade, G. Weiss, David Cherba, 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Phase II Trial to Evaluate Gemcitabine and Etoposide for Locally Advanced or Metastatic Pancreatic Cancer

G. V. Vande Woude, H. Koo, K. Yost, 2010, Molecular Cancer Therapeutics.

cular Medicine in Practice se II Trial to Evaluate Gemcitabine and Etoposide for Ther ally Advanced or Metastatic Pancreatic Cancer

H. Koo, K. Yost, C. Webb, 2010 .

Phase II Trial to Evaluate Gemcitabine and Etoposide for Locally Advanced or Metastatic Pancreatic Cancer

G. V. Vande Woude, H. Koo, K. Yost, 2010, Molecular Cancer Therapeutics.

cular Medicine in Practice se II Trial to Evaluate Gemcitabine and Etoposide for Ther ally Advanced or Metastatic Pancreatic Cancer

H. Koo, K. Yost, C. Webb, 2010 .